Setting the Standard Since 1971
Cart 0

Injectable Drug Compatibility News

New injectable drug compatibility & stability for Spring 2021

In this update we added new monographs for COVID-19 VACCINE, EPTINEZUMAB-JJMR; IMIPENEM, CILASTATIN, AND RELEBACTAM; and SACITUZUMAB GOVITECAN-HZIY. We also added new stability information to these existing drug monographs:  FOSPHENYTOIN SODIUM, METHADONE HYDROCHLORIDE, and MILRINONE LACTATE. New compatibility information was added to these existing drug monographs: ALPROSTADIL, AMIODARONE HYDROCHLORIDE, BUMETANIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DOPAMINE HYDROCHLORIDE, EPINEPHRINE HYDROCHLORIDE, ESMOLOL HYDROCHLORIDE, FENTANYL CITRATE, FUROSEMIDE, HEPARIN SODIUM, MILRINONE LACTATE, NICARDIPINE HYDROCHLORIDE, NITROPRUSSIDE SODIUM, TOTAL PARENTERAL NUTRITION SOLUTIONS, VASOPRESSIN; and IMIPENEM, CILASTATIN, AND RELEBACTAM with nine different parenteral drugs.

Read more →


COVID-19 Vaccine Product, Storage, & Stability Information

COVID-19 Vaccine Product, Storage, and Stability Information is now available from King Guide. Click To View

Read more →


New Injectable Drug Compatibility & Stability Information

The King Guide Winter 2020 update includes 3 new injectable drugs, new stability for 21 drugs, and new compatibility for 18 drugs.

Read more →


New IV Drug Compatibility & Stability - Fall 2020

In this update we added a new monograph for FERRIC DERISOMALTOSE. We also added new stability information to these existing drug monographs: ASCORBIC ACID, CALCIUM GLUCONATE, CLONIDINE HYDROCHLORIDE, CLOXACILLIN SODIUM, ETOPOSIDE, LORAZEPAM, MAGNESIUM SULFATE, MIDAZOLAM HYDROCHLORIDE, MILRINONE LACTATE, PHYTONADIONE, and VANCOMYCIN HYDROCHLORIDE. In addition, new compatibility information is reported for these drugs: BACLOFEN, CALCIUM CHLORIDE, CALCIUM GLUCONATE, DOPAMINE HYDROCHLORIDE, NITROPRUSSIDE SODIUM, ROPIVACAINE HYDROCHLORIDE, SUFENTANIL CITRATE, TOTAL PARENTERAL NUTRITION SOLUTIONS, and TREPROSTINIL SODIUM.

Read more →


New IV Drug Compatibility & Stability for Summer 2020

Summer 2020 This is the 216th quarterly update to the King® Guide to Parenteral Admixtures® Online & Loose-Leaf Editions. New Monograph GLUCAGON New Stability Information  ALPROSTADIL, ALTEPLASE, CEFOTAXIME, CEFTOLOZANE AND TAZOBACTAM, COLISTIMETHATE SODIUM, DIAZEPAM, FLUOROURACIL, IBUPROFEN, ISOSORBIDE DINITRATE, MEROPENEM AND VABORBACTAM, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NOREPINEPHRINE BITARTRATE, TORSEMIDE, VANCOMYCIN HYDROCHLORIDE, and VORICONAZOLE. New Compatibility Information CIPROFLOXACIN, FUROSEMIDE, IBUPROFEN, INSULIN, REGULAR, KETAMINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE, LINEZOLIDE, MEROPENEM, PERITONEAL DIALYSIS SOLUTIONS, PROPOFOL, REMIFENTANIL HYDROCHLORIDE, TOTAL PARENTERAL NUTRITION SOLUTIONS, and VANCOMYCIN HYDROCHLORIDE.   

Read more →